Latest It Services News

Way2VAT is advancing its position as a global leader in digital tax processing through a strategic acquisition and a robust four-pillar growth plan, targeting profitability by 2026 amid expanding market opportunities.

Way2VAT Ltd has secured a strategic acquisition of UK-based RBC VAT Limited alongside a $4.1 million placement, accelerating its expansion in VAT compliance and consultancy services.

Telix Pharmaceuticals secures Transitional Pass-Through payment status for its next-generation prostate cancer imaging agent Gozellix, paving the way for broader US patient access and streamlined provider reimbursement.

Mineral Resources Limited has priced a US$700 million senior unsecured notes offering at 7.000%, aiming to refinance its existing higher-cost debt due in 2027. The move signals a strategic effort to optimise its capital structure amid evolving market conditions.

Sprintex Limited has secured a significant A$16.6 million order to supply integrated control systems for Mest Water’s innovative manure processing units, marking a major step in sustainable agriculture technology in the Netherlands.

Alcidion Group has expanded its contract with North Cumbria Integrated Care NHS Foundation Trust to integrate MediViewer into its Miya Precision electronic patient record system, enhancing access to scanned and historical documents.

Saunders International appoints Angelo De Angelis as CEO effective October 2025, succeeding Mark Benson who will support the transition through 2026. This leadership change signals a steady hand guiding the company’s next growth phase.

EBR Systems has secured final CMS approval for Transitional Pass-Through reimbursement for its WiSE CRT System, effective October 1, 2025, enhancing hospital adoption prospects in the U.S.

Environmental Clean Technologies Limited (ECT) has requested a voluntary suspension of its shares on the ASX as it prepares to announce a significant acquisition and capital raising.

ReNerve Ltd has launched its Empliq product range, marking its entry into the dermal and amniotic tissue repair markets with first sales already recorded and a US launch planned.

Emyria secures a multi-year funding agreement with Medibank to support its Treatment-Resistant Depression program, marking a first for insurer-backed psychotherapy in Australia.

Reece Limited has announced an off-market share buy-back targeting $250 million, with flexibility up to $400 million, offering shareholders a premium price range between $11.00 and $13.00 per share. This move aims to return excess capital while preserving financial flexibility for future growth.